The researchers found that in men, but not in women, increasing CXCL9 levels were associated with an increasing risk for hip fracture. The odds ratios in the highest quartile compared with the lowest quartile were 10.35 (95 percent confidence interval, 1.90 to 56.39) and 1.46 (95 percent confidence interval, 0.59 to 3.60) in men and women, respectively.
According to a recent study published in Arthritis & Rheumatology and conducted by Baylor College of Medicine researchers, walking may help people age 50 and older who have knee osteoarthritis, the most prevalent kind of arthritis, reduce frequent pain.
It is not surprising some people want to try different diets, supplements or therapies to see if they alleviate symptoms or help them gain a sense of control over their condition. So what does the evidence say about supplements?
If you feel like your back has gone out, you may have your hips to blame. Tight hip flexors affect your lumbar spine, contributing to your risk of lower back pain.
Patellofemoral arthritis is a form of knee arthritis. It affects the joint where the kneecap meets the thighbone. People with patellofemoral arthritis may experience pain and stiffness in the knee, difficulty walking, and other symptoms that impact their quality of life.
A study of over 26,000 middle-aged UK women reveals those with a vegetarian diet had a 33% higher risk of hip fracture compared to regular meat-eaters.
Each year more than 70,000 older adults are admitted to a U.K. hospital after a hip fracture, which can lead to a decline in quality of life, high mortality risk and, after discharge, high risk of emergency hospital readmission.
Experimental technology could transform the surface of implants so bacteria won’t grow and cause infections in procedures such as knee and hip replacements
Long - term adherence to antiosteoporosis medication (AOM) in the setting of a fracture liaison service (FLS) are not well known. Patients ≥ 50 with hip fracture seen in an FLS and recommended for treatment to prevent new fractures were analyzed.
Patients with knee osteoarthritis receiving antihistamines demonstrate less structural disease progression, compared with those who did not take antihistamines, over 2 years, according to data presented at the EULAR 2022 Congress.